中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents

文献类型:期刊论文

作者Peng, Wei ; Tu, Zheng-Chao ; Long, Zi-Jie ; Liu, Quentin ; Lu, Gui
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
出版日期2016
卷号108页码:644-654
ISSN号0223-5234
学科主题Pharmacology & Pharmacy
语种英语
公开日期2016-12-16
源URL[http://ir.gibh.ac.cn/handle/344009/900]  
专题广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文
推荐引用方式
GB/T 7714
Peng, Wei,Tu, Zheng-Chao,Long, Zi-Jie,et al. Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2016,108:644-654.
APA Peng, Wei,Tu, Zheng-Chao,Long, Zi-Jie,Liu, Quentin,&Lu, Gui.(2016).Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,108,644-654.
MLA Peng, Wei,et al."Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 108(2016):644-654.

入库方式: OAI收割

来源:广州生物医药与健康研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。